Licensing Fees Drop as Partner Production Stalls
Licensors that depend on partner manufacturing should watch supply disruptions closely, since they can cut royalty income within a single quarter.
Updated on Nov. 5, 2026 in Corporate Finance

Live Poll
Do you trust large companies to keep their promises to customers?
Research Frontiers reported third-quarter 2026 results, showing fee income of $77,041 against $359,444 a year earlier and a net loss of $510,304, or $0.01 per share. The company's licensing income fell as Gauzy's disrupted SPD production affected its supply chain.
Why it matters
For small licensors and technology firms, reliance on a partner's production capacity can translate directly into lost royalty income. The company's cash of roughly $645,000 and lack of debt set the limit on how long it can absorb a sustained revenue gap.
Fee income fell about 79% year over year, from $359,444 to $77,041, while the quarterly net loss rose from $298,508 to $510,304. The company reported approximately $645,000 in cash and no debt at September 30, 2026, with 34,867,786 common shares outstanding.
The players
Research Frontiers
A New York-based licensor of SPD light-control technology that earns royalties and fees from manufacturing partners rather than producing goods itself.
Gauzy
An SPD manufacturer whose emulsion and film production in Israel and Germany supplies the technology used in partner products, and which announced new financing and debt restructuring in October 2026.
The details
Research Frontiers earns fees from licensing its suspended particle device (SPD) light-control technology, so its income depends on the manufacturing activity of partners. This quarter's decline reflects a nonrecurring government-contract royalty in the 2025 period and disruption of SPD emulsion and film production at Gauzy. Partly offsetting this, royalties rose from motorcycle helmet and ski and snow goggle applications. Gauzy has restarted SPD emulsion production in Israel and SPD film production in Germany, but the pace of recovery remains an open question.
Timeline
September 30, 2025: comparison period for the 2025 quarterly and nine-month results ends.
October 2026: Gauzy announced new financing and restructuring of its liabilities.
September 30, 2026: third-quarter 2026 reporting period ends.
November 5, 2026: Research Frontiers reports Q3 results and holds a conference call.
November 6, 2026: a replay of the conference call becomes available for 90 days.
Market Landscape
SPD-SmartGlass was selected for electronically dimmable windows on two new aircraft models, and a third new aircraft using SPD-Smart technology was unveiled in North America. These aerospace programs point to future royalty opportunities even as near-term fee income has been disrupted by production problems at a manufacturing partner.
Operators of licensing or royalty-based businesses should watch how dependent their income is on partner production schedules, since a manufacturing disruption can cut fee income sharply in a single quarter. Companies in this position should review cash runway against sustained revenue declines with a qualified accountant.
The takeaway
Licensing revenue can fall quickly when a manufacturing partner is disrupted, so track partner production status alongside your own cash position. Watch the November 5, 2026 conference call for management's account of the SPD supply chain and liquidity.
What happens next
Research Frontiers will report results and hold a conference call on November 5, 2026, where management expects to discuss Gauzy developments, the SPD supply chain, and liquidity.
Further reading
For context on how company earnings and capital position are tracked, see the Corporate Finance section.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you trust large companies to keep their promises to customers?








